Key facts
- Notable investors include ChuangVest Ventures, Hangzhou Huadian Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ominira
- ·The full record, as it builds
Funding rounds
No funding rounds for Ominira are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ominira
Manufacturer of medical beauty products intended for cutting-edge medical beauty technology trends and Chinese local market insights. The company offers a platform enterprise that integrates production, research, sales, and medical-grade technology beauty products, thereby catering to customers to create a real and beautiful life experience.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2023
- Website
- ominira.cn/
- Ownership
- Privately Held (backing)
Ominira doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ominira shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ominira in its N-PORT filings yet. We sweep new filings monthly.